| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |